MedTrace Logo

Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)

NCT02275546 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2024-05-17

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to assess the performance and safe use of the vaginal ring applicator as an optional aid for insertion of a placebo vaginal ring into the vagina in healthy women

Conditions

  • Contraception: Optional Applicator for Insertion of Vaginal Ring

Interventions

DRUG

Placebo vaginal ring

Drug-free placebo vaginal ring

DEVICE

Single-use, non-sterile applicator

Single-use, non-sterile, plastic applicator for insertion of vaginal ring.

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-11
Primary Completion
2015-04-10
Completion
2015-04-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02275546 on ClinicalTrials.gov